Tesamorelin 10mg
An FDA-approved analogue with over 30 published studies behind it. Widely studied for its role in natural hormonal signaling and its well-documented safety profile in clinical research.
How It Works
The Target
Growth Hormone Releasing Hormone (GHRH) receptors on pituitary cells. Tesamorelin is a modified version of natural GHRH, engineered to resist enzymatic breakdown.
The Mechanism
Binds to GHRH receptors on the pituitary gland, triggering natural pulsatile growth hormone release. Unlike synthetic GH injection, it preserves the body's own feedback loops — GH is released in natural patterns rather than as a constant level.
Why It Matters
FDA-approved for HIV-associated lipodystrophy. The preserved pulsatile release pattern means the body's regulatory systems stay intact, with demonstrated effects on visceral fat reduction and improved body composition.
Specifications
| Purity | >=98% (HPLC) |
| MW | ~5.1 kDa |
| Form | Lyophilized powder |
| Storage | -20 degrees C |
| Reconstitution | Bacteriostatic water |
| Shelf Life | 24 months |
Published References
Read the research: Tesamorelin GHRH-receptor signaling & GH/IGF-1 axis pharmacology →